ARCHIVES

IOM Calls FDA Advisory System Sounds, Suggests Conflict Criteria Changes

This article is from The Cancer Letter archive.

Vol. 19 No. 10 | March 5, 1993

Download PDF Visit The Full Archive

Related Articles

Harkin, Bumpers Concerned Over Centers Funding

May 5, 1989

Study: Keytruda Improves PFS In Ipilimumab-Refactory Disease

November 28, 2014

Source Identified for Hepatitis A Contamination of LAK-IL-2 Trials; Six MIs Seen; Rosenberg Updates Intramural Results

October 24, 1986

RFAs For New Improve Accrual Of Minorities, Women

February 2, 1996

Cancer Advocates Use Benefit Analysis To Press For Funds

May 11, 1990

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006